ARCHIVES

Celebrex Studies Show Polyp Reduction, Point To Challenges In Biomarker Validation

This article is from The Cancer Letter archive.

Vol. 29 No. 4 | April 28, 2006

Download PDF Visit The Full Archive

Related Articles

Includes Sept. Business & Regulatory Report.

September 26, 2003

ACCC Seeks Expanded Backing For CHOP, Other Community Cancer Programs

November 7, 1980

ACS Issues Challenge To cut Death Rate From Cancer In Half

November 22, 1996

Zometa Reduced Bone Complications In Patients With Prostate Cancer Bone Mets

October 25, 2002

BRMP Projects Priority Rated

April 11, 1980

Pfizer Begins Phase III Trial Of Sunitinib In NSCLC

September 28, 2007